INNV InnovAge Holding Corp.
Services-Health Services · Nasdaq · SEC CIK 1834376 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY15.1%
TTM net income YoY151.8%
TTM EPS YoY150.0%
Revenue 3-yr CAGR13.3%
Net income 3-yr CAGR—
Margins
Gross margin23.6%
Operating margin1.4%
Net margin0.9%
FCF margin7.5%
EBITDA margin3.6%
Returns
ROE3.6%
ROA1.7%
ROIC (approx.)5.4%
Asset turnover1.90x
Leverage & solvency
Liabilities / assets48.6%
Debt / equity0.19x
Current ratio1.16x
Interest coverage—
Cash quality & payout
Operating cash flow / net income9.95x
Accruals ratio-15.0%
Payout ratio—
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-30 | 2026Q4*2026-06-30 | 2026Q32026-03-31 | 2026Q22025-12-31 | 2026Q12025-09-30 | 2025Q4*2025-06-30 | 2025Q32025-03-31 | 2025Q22024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $264.76M | $261.95M | $251.94M | $239.71M | $236.10M | $221.42M | $218.14M | $209.00M |
| Gross profit | $63.59M | $62.56M | $61.02M | $52.83M | $51.36M | $41.29M | $40.75M | $37.06M |
| SG&A expense | $29.15M | $33.08M | $76.53M | $26.61M | $30.27M | $27.82M | $38.60M | $28.10M |
| Operating income | $20.15M | $10.15M | -$29.08M | $13.26M | $8.29M | -$2.15M | -$10.16M | -$12.56M |
| Income tax | -$841,000 | -$116,000 | $167,000 | $651,000 | $247,000 | $807,000 | $72,000 | $34,000 |
| Net income | $19.55M | $8.29M | -$29.46M | $10.62M | $8.02M | -$785,000 | -$11.38M | -$13.22M |
| EBITDA | $25.81M | $16.50M | -$24.25M | $18.14M | $13.37M | $1.24M | -$4.77M | -$7.24M |
| EPS (basic) | 0.14 | — | -0.22 | 0.08 | 0.06 | — | -0.08 | -0.10 |
| EPS (diluted) | 0.14 | — | -0.22 | 0.08 | 0.06 | — | -0.08 | -0.10 |
| Weighted avg. shares (diluted) | 137.07M | — | 135.70M | 136.35M | 136.76M | — | 135.20M | 135.44M |
| Balance sheet | ||||||||
| Cash & equivalents | $119.25M | $97.89M | $95.54M | $83.20M | $67.16M | $64.14M | $60.47M | $46.09M |
| Short-term investments | $43.74M | $43.44M | $43.05M | $42.76M | $42.27M | $41.77M | $41.28M | $40.77M |
| Receivables | $25.50M | $42.39M | $28.58M | $21.30M | $23.17M | $36.37M | $44.40M | $49.76M |
| Current assets | $223.78M | $214.31M | $202.61M | $181.85M | $161.70M | $176.11M | $176.18M | $167.95M |
| PP&E, net | $163.69M | $166.09M | $165.35M | $164.59M | $166.28M | $168.04M | $177.50M | $179.02M |
| Goodwill | $142.05M | $142.05M | $142.05M | $142.05M | $142.05M | $142.05M | $142.05M | $139.95M |
| Intangibles | $3.05M | $3.22M | $3.38M | $3.55M | $3.71M | $3.88M | $4.04M | $4.21M |
| Total assets | $562.96M | $557.39M | $547.39M | $527.48M | $510.23M | $526.85M | $536.65M | $524.78M |
| Current liabilities | $192.48M | $203.89M | $195.89M | $144.70M | $138.49M | $164.81M | $225.32M | $144.97M |
| Short-term debt | $2.54M | $2.54M | $2.54M | $2.54M | $3.00M | $2.25M | $60.98M | $3.79M |
| Long-term debt | $44.98M | $45.52M | $55.43M | $55.99M | $56.15M | $57.46M | $1.76M | $59.80M |
| Total debt | $47.51M | $48.06M | $57.97M | $58.53M | $59.16M | $59.71M | $62.75M | $63.59M |
| Total liabilities | $273.75M | $288.62M | $288.50M | $238.72M | $234.47M | $263.94M | $268.94M | $246.83M |
| Shareholders' equity | $255.34M | $235.60M | $229.03M | $256.79M | $244.98M | $234.97M | $237.96M | $248.46M |
| Net debt | -$71.74M | -$49.83M | -$37.57M | -$24.68M | -$8.00M | -$4.43M | $2.28M | $17.50M |
| Shares outstanding | 136.46M | 136.02M | 135.71M | 135.70M | 135.68M | 135.44M | 135.08M | 135.35M |
| Cash flow statement | ||||||||
| Operating cash flow | $28.74M | $21.29M | $18.14M | $21.36M | $3.92M | $9.00M | $24.63M | $6.75M |
| Capital expenditure | $2.99M | $4.27M | $3.60M | $2.36M | $4.08M | -$179,000 | $2.90M | $1.34M |
| Free cash flow | $25.75M | $17.02M | $14.54M | $19.00M | -$153,000 | $9.18M | $21.73M | $5.41M |
| Investing cash flow | -$3.42M | -$4.82M | -$3.80M | -$2.90M | -$814,000 | $976,000 | -$8.14M | $4.40M |
| Financing cash flow | -$3.96M | -$14.11M | -$2.01M | -$2.40M | -$11,000 | -$5.25M | -$2.12M | -$4.09M |
| Depreciation & amortization | $5.66M | $6.36M | $4.82M | $4.88M | $5.08M | $3.39M | $5.39M | $5.32M |
| Stock-based compensation | $1.74M | $1.73M | $1.79M | $1.22M | $2.31M | $1.55M | $2.04M | $1.87M |
Free plan shows the latest 8 periods; Pro shows all 27 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.